Low-dose weekly administration of docetaxel for metastatic breast cancer
Kimijima, I.; Watanabe, T.; Sagara, H.; Ohtake, T.; Tsuchiya, A.; Abe, R.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 995-999
1999
ISSN/ISBN: 0385-0684 PMID: 10396330 Document Number: 504521
Document emailed within 1 workday
Related Documents
Kimura, M.; Sano, M.; Tabei, T.; Asaga, T.; Ando, J.; Fujii, H.; Yamamoto, N.; Kurosumi, M. 2005: Study of three-weekly docetaxel and weekly trastuzumab treatment in HER 2-overexpressing metastatic breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(3): 335-339Kim, Y.; Takatsuka, Y.; Gotoh, K.; Hasegawa, S.; Aritake, N.; Kan, K.; Fukunaga, M.; Touno, T.; Oozato, H.; Imamoto, H.; Yamazaki, K.; Maruyama, H. 1999: Pharmacological study of weekly docetaxel in patients with metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(10): 1437-1441
Coccaro, M.; Tartarone, A.; Romano, G.; Ardito, R.; Di Renzo, N. 2005: Dose-finding study of weekly docetaxel plus estramustine in patients with hormone-refractory metastatic prostate cancer Tumori 91(4): 314-316
Kimura, M.; Koida, T.; Yanagita, Y. 2000: Weekly administration of paclitaxel for advanced or metastatic breast cancer--short-course premedications for outpatients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(11): 1703-1708
Slee, P.H.T.J.; Rodenburg, C.J.; Nortier, J.W.R.; van Bochove, A. 2004: A phase i dose-escalating study of docetaxel plus folinic acid and 5-fluorouracil in anthracycline-pretreated patients with metastatic breast cancer Netherlands Journal of Medicine 62(9): 314-319
Seidman, A.D.; Hudis, C.A.; McCaffrey, J.; Tong, W.; Currie, V.; Moynahan, M.E.; Theodoulou, M.; Tepler, I.; Gollub, M.; Norton, L. 1997: Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer Seminars in Oncology 24(5 Suppl 17: S17
Okubo, A.; Hino, N.; Ikushima, Y.; Mori, R.; Amano, S.; Tsuyuguchi, M.; Sounaka, Y.; Wada, D.; Yamasaki, S.; Miyake, H.; Miyoshi, T.; Ikawa, K.; Ogata, Y.; Matsuoka, H.; Kawakita, N.; Mikami, C. 2010: Two elderly patients with advanced breast cancer successfully treated by tri-weekly docetaxel Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 911-914
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Aapro, M.S. 1997: Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer Oncology 11(8 Suppl 8: 46-49
Diéras, V. 1997: Review of docetaxel/doxorubicin combination in metastatic breast cancer Oncology 11(8 Suppl. 8): 31-33
Chan, S. 1997: Docetaxel vs doxorubicin in metastatic breast cancer resistant to alkylating chemotherapy Oncology 11(8 Suppl 8: 19-24
Specenier, P.; Thomas, J. 1986: Weekly low-dose doxorubicin in advanced breast cancer Cancer Treatment Reports 70(6): 815
Lissoni, P.; Vaghi, M.; Ardizzoia, A.; Fumagalli, E.; Tancini, G.; Gardani, G.; Conti, A.; Maestroni, G.J. 2001: Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancer Neuro Endocrinology Letters 22(1): 27-29
Jönsson, P.E.; Malmberg, M.; Ericsson, M.; Ryden, S. 1991: Weekly dose adriamycin as first line chemotherapy in advanced breast cancer Anticancer Research 11(2): 877-879
Chang, A.Y.; Boros, L.; Asbury, R.; Hui, L.; Rubins, J. 1997: Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer Seminars in Oncology 24(5 Suppl 17: S17
Takahashi, H.; Takahashi, M.; Taguchi, K.; Sasaki, F.; Todo, S. 2003: Weekly paclitaxel administration in the adjuvant therapy of primary breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(5): 653-659
Katsumata, K.; Yamamoto, K.; Ashizawa, T.; Sumi, T.; Murohashi, T.; Katayanagi, S.; Kusama, M.; Koyanagi, Y. 2001: Recurrent breast cancer successfully treated with a weekly dose of paclitaxel--a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(1): 75-78
Christodoulou, C.; Klouvas, G.; Pateli, A.; Mellou, S.; Sgouros, J.; Skarlos, D.V. 2003: Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer Anticancer Research 23(1b): 737-744
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504
Cosmas, C.; Tsavaris, N.; Malamos, N.; Tsakonas, G.; Gassiamis, A.; Skopelitis, H.; Soukouli, G.; Polyzos, A.; Mylonakis, N.; Karabelis, A. 2005: Dose escalation of docetaxel and ifosfamide in patients with advanced breast cancer failing prior anthracyclines: mature results of a phase I-Ii study Journal of Buon: Official Journal of the Balkan Union of Oncology 10(3): 337-346